{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:47:20Z","timestamp":1761569240198,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA091842-20S2"],"award-info":[{"award-number":["P30 CA091842-20S2"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clgc.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T13:37:10Z","timestamp":1641908230000},"page":"e227-e232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-5696","authenticated-orcid":false,"given":"Amit","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-1746","authenticated-orcid":false,"given":"Randall","family":"Brenneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiram A","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-1413","authenticated-orcid":false,"given":"Brian C.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2022.01.006_bib0001","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2022.01.006_bib0002","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2022.01.006_bib0003","article-title":"Association of treatment modality, functional outcomes, and baseline characteristics with treatment-related regret among men with localized prostate cancer","author":"Wallis","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0360-3016(97)00554-3","article-title":"Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer","volume":"40","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)53012-8","article-title":"Impotence following radical prostatectomy: insight into etiology and prevention","volume":"128","author":"Walsh","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.283.3.354","article-title":"Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study","volume":"283","author":"Stanford","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clgc.2022.01.006_bib0007","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.ijrobp.2009.04.094","article-title":"Radiation dose\u2013volume effects and the penile bulb","volume":"76","author":"Roach","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.adro.2016.10.002","article-title":"ACR Appropriateness Criteria\u00ae external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II","volume":"2","author":"Zaorsky","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0009","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.adro.2017.03.003","article-title":"ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II","volume":"2","author":"Zaorsky","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0360-3016(02)02805-5","article-title":"Penile bulb imaging","volume":"53","author":"Wallner","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0011","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0360-3016(03)01446-9","article-title":"Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate","volume":"57","author":"Steenbakkers","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clgc.2022.01.006_bib0012","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1016\/j.ijrobp.2019.06.1964","article-title":"Real-time MRI-guided prostate stereotactic body radiation therapy: impact on treatment delivery and implications","volume":"105","author":"Agrawal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phro.2019.02.002","article-title":"Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer","volume":"9","author":"Tetar","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2018.08.010","article-title":"Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-year clinical experience","volume":"30","author":"Henke","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0016","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.prro.2018.12.004","article-title":"Delineation of a cardiac planning organ-at-risk volume using real-time magnetic resonance imaging for cardiac protection in thoracic and breast radiation therapy","volume":"9","author":"Henke","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0018","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijrobp.2018.08.016","article-title":"Acute toxicity profiles of hypofractionated adjuvant and salvage radiation therapy after radical prostatectomy: results of a prospective study","volume":"103","author":"Saldi","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0019","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2019.11.005","article-title":"Stereotactic body radiation therapy to the prostate bed: results of a phase 1 dose-escalation trial","volume":"106","author":"Sampath","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0021","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0022","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0023","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.2006.09.8046","article-title":"Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer","volume":"25","author":"Smith","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0024","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2003.12.028","article-title":"Erectile dysfunction and radiation dose to penile base structures: a lack of correlation","volume":"59","author":"Selek","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2007.10.052","article-title":"Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial","volume":"71","author":"van der Wielen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0026","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2004.05.030","article-title":"Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer","volume":"60","author":"Wernicke","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0027","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ijrobp.2004.05.026","article-title":"Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I\/II dose-escalation study","volume":"60","author":"Roach","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0028","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2020.01.022","article-title":"Erectile dysfunction and absorbed dose to penile base structures in a randomized trial comparing ultrahypofractionated and conventionally fractionated radiation therapy for prostate cancer","volume":"107","author":"Rasmusson","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0029","first-page":"28","article-title":"Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT","volume":"61","author":"Jaccard","year":"2019","journal-title":"Phys Medica PM Int J Devoted Appl Phys Med Biol Off J Ital Assoc Biomed Phys AIFB"},{"key":"10.1016\/j.clgc.2022.01.006_bib0030","first-page":"77","article-title":"Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial","volume":"21","author":"Murray","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0031","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.prro.2017.07.008","article-title":"Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal\/prostate spacer: Secondary analysis of a phase 3 trial","volume":"8","author":"Hamstra","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0032","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.adro.2017.12.008","article-title":"Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database","volume":"3","author":"Burt","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14674","article-title":"Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US","volume":"3","author":"Agrawal","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clgc.2022.01.006_bib0034","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/cncr.21441","article-title":"Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era","volume":"104","author":"Soloway","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2022.01.006_bib0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prro.2018.08.002","article-title":"Hypofractionated radiation therapy for localized prostate cancer: executive summary of an astro, asco, and aua evidence-based guideline","volume":"8","author":"Morgan","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0036","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2019.07.008","article-title":"SBRT for localized prostate cancer: is it ready for take-off?","volume":"105","author":"Mitin","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2022.01.006_bib0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2019.08.017","article-title":"Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients","volume":"141","author":"Martell","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0090-4295(99)80421-X","article-title":"Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins","volume":"47","author":"Connolly","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2022.01.006_bib0039","article-title":"Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy","volume":"12","author":"Beck","year":"2017","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.clgc.2022.01.006_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/0284186X.2013.837584","article-title":"Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis","volume":"53","author":"Zilli","year":"2014","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.clgc.2022.01.006_bib0041","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eururo.2011.04.021","article-title":"High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results","volume":"60","author":"Ost","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jmir.2017.10.002","article-title":"The utility of penile bulb contouring to localise the prostate apex as compared to urethrography","volume":"49","author":"Lock","year":"2018","journal-title":"J Med Imaging Radiat Sci"},{"key":"10.1016\/j.clgc.2022.01.006_bib0043","article-title":"On behalf of the GFRU (francophone group of urological radiotherapy)","volume":"10","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clgc.2022.01.006_bib0044","series-title":"Radiologic Society of North America (RSNA) Annual Meeting","article-title":"Penile bulb inter-fraction organ motion during prostate cancer radiotherapy","author":"Brenneman","year":"2020"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:34:56Z","timestamp":1761564896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767322000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1558767322000192"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2022.01.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}